Skip to main content

Peer Review reports

From: Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis

Original Submission
24 May 2022 Submitted Original manuscript
4 Aug 2022 Reviewed Reviewer Report - Charles Stiller
10 Sep 2022 Reviewed Reviewer Report - Sinan T. Shukur
21 Sep 2022 Author responded Author comments - Ye Yuan
Resubmission - Version 2
21 Sep 2022 Submitted Manuscript version 2
8 Nov 2022 Editorially accepted
10 Dec 2022 Article published 10.1186/s13643-022-02134-9

You can find further information about peer review here.

Back to article page